ストックスクリーナーアプリを入手
0.3076
0.36%
0.0007
前日終値:
$0.3069
開ける：
$0.308
24時間の取引高:
1.01M
Relative Volume:
1.18
時価総額：
$16.10M
収益：
$65.27M
当期純損益:
$-19.15M
株価収益率:
-0.4955
EPS:
-0.6208
ネットキャッシュフロー:
$-12.43M
1週間 パフォーマンス:
-13.24%
1か月 パフォーマンス:
+2.67%
6か月 パフォーマンス:
-57.81%
1年 パフォーマンス:
-28.27%
1日の値動き範囲:
$0.297
$0.3367
1週間の範囲:
$0.297
$0.3662
52週間の値動き範囲:
$0.2805
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
名前
Cosmos Health Inc
セクター
電話
312-536-3102
住所
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3077 | 16.06M | 65.27M | -19.15M | -12.43M | -0.6208 |
MCK
Mckesson Corp
|
737.27 | 87.17B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
263.45 | 50.53B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
184.34 | 42.74B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
69.97 | 7.86B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.08 | 1.81B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc (COSM) 最新ニュース
Cosmos Health stock (US22143K1016): Fort18 launch targets $3.2M revenue boost - AD HOC NEWS
Cosmos Health withdraws SEC registration statement - Investing.com
Cosmos Health withdraws SEC registration statement By Investing.com - Investing.com Canada
Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 - guardonline.com
Cosmos Health scraps public offering, pulls SEC registration - Stock Titan
[RW] Cosmos Health Inc. SEC Filing - Stock Titan
Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months - ACCESS Newswire
Men's stamina supplement Fort18 targets $3.2M U.S. sales - Stock Titan
Cosmos Health Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
COSM introduces new product for sexual health - MSN
Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed - ACCESS Newswire
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health Introduces the "18 Series" in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products - Quantisnow
COSM Stock Price, Quote & Chart | COSMOS HEALTH INC (NASDAQ:COSM) - ChartMill
Number of shareholders of Cosmos Health Inc. – NASDAQ:COSM - TradingView
Cosmos Health launches Fort18 men’s wellness supplement in U.S. By Investing.com - Investing.com Australia
Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com UK
Cosmos Health Introduces Fort18 in the United StatesA Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness - ACCESS Newswire
Cosmos Health enters men's wellness as U.S. market heads to $1.93B - Stock Titan
Cosmos Health (COSM) price target increased by 50.00% to 4.59 - MSN
Cosmos Health (COSM) Projects Significant Revenue Growth with Cu - GuruFocus
Cosmos Health projects Cur18 to generate $2.5M in U.S. revenue - Investing.com Australia
Cosmos Health projects Cur18 to generate $2.5M in U.S. revenue By Investing.com - Investing.com South Africa
Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months - ACCESS Newswire
A turmeric supplement is central to Cosmos Health's $2.5M U.S. sales bet - Stock Titan
Cosmos Health Continues US Expansion with Q2 Launch of Cur18a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health - ACCESS Newswire
Cosmos Health (COSM) holder reports 4.14M shares, 8.15% stake in amendment - Stock Titan
Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Produ - Palestineherald.com
73.5M Cosmos Health shares registered for resale (NASDAQ: COSM) - Stock Titan
Cosmos Health (COSM) Year-Ahead Outlook | Q4 2025: Below ExpectationsAcquisition - Xã Vĩnh Công
Is Cosmos Health (COSM) stock still a good play today | Q4 2025: Profit DisappointsReal-time Trade Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Cosmos Health (COSM) Stock: Consolidation Phase Insight (Smart Money Flows) 2026-04-22Quantitative Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Cosmos Health Inc.: Cosmos Health Introduces the 18 Series in the United StatesA Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Valid - FinanzNachrichten.de
Cosmos Health to begin Liv18 liver supplement production in April By Investing.com - Investing.com Australia
COSM earnings show rapid revenue growth - MSN
Cosmos Health Inc (COSM) 財務データ
収益
当期純利益
現金流量
EPS
2.37%
1.92%
大文字化:
|
ボリューム (24 時間):